Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension
Manish Saxena, Lisa Usdan(Launchpad Central (United States)), И. Н. Лукьянов(Launchpad Central (United States)), Brian Taylor Slingsby, Jalal K. Ghali(Launchpad Central (United States)), David Rodman, Matthew R. Weir(University of Maryland, Baltimore), Liffert Vogt(Amsterdam University College), Keung Lee(Launchpad Central (United States)), Leticia Jimenez(Launchpad Central (United States)), Andres Patron(Launchpad Central (United States)), Atul Chugh(Launchpad Central (United States)), Sujeeta Dhakhwa(Launchpad Central (United States)), Branko Kopjar(University of Washington), Andrew Chow(Launchpad Central (United States)), Frank Strutz(Nierenzentrum Heidelberg), Fadi Chalhoub(Massachusetts General Hospital), Luke J. Laffin(Cleveland Clinic), John Lentz(Launchpad Central (United States)), Tatyana Miroshnikova(Launchpad Central (United States)), Simon D. Roger, Leticia Goodwin(Launchpad Central (United States)), E M Cantero Perez(Launchpad Central (United States)), Krishna R. Polu, Vijay U. Rao(Launchpad Central (United States)), Kaitlin Ziedonis(Launchpad Central (United States)), Lora McGill(Launchpad Central (United States)), Susan Angel(Launchpad Central (United States)), Claudio Borghi(Launchpad Central (United States)), Alexandra Lynch(Launchpad Central (United States)), Beatriz Fernandez(Hospital Universitario Fundación Jiménez Díaz), M Izquierdo Patrón(Launchpad Central (United States)), Jai Radhakrishnan(Launchpad Central (United States)), Felipe Suplicy(Launchpad Central (United States)), Robert Molpus(Launchpad Central (United States)), Beckie Klipper(Launchpad Central (United States)), Karla Alfonsin(Launchpad Central (United States)), Paul Lunseth(Launchpad Central (United States)), George Kaleel Rafeedie(Launchpad Central (United States)), George Rafeedie(Launchpad Central (United States)), Luis A. Diaz-Secades(Launchpad Central (United States)), Damarys Sacasa(Launchpad Central (United States)), Nandita Joshi Jones(Launchpad Central (United States)), Ayanna Guzman-Nguyen(Launchpad Central (United States)), Lon Lynn(Launchpad Central (United States))
Cited by 65
Related Papers
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
|New England Journal of Medicine|2014|658
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
|Nature Genetics|2008|646
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|609
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
|Kidney International|2016|474
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
|Nephrology Dialysis Transplantation|2020|411